Clinical Trials

366 enrolled

Breast Neoplasms

NCT02465736 2024-01-16

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

610 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03926091 2023-11-14

CLOVER

2,172 enrolled

Breast Neoplasms

NCT05673590 2023-11-08

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

612 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05673629 2023-11-08

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

552 enrolled

Breast Neoplasms

NCT05985187 2023-08-14

Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.

412 enrolled

HER2-positive Breast Cancer

NCT04139772 2023-03-24

Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.

18 enrolled

Metastatic Castration-resistent Prostate Cancer

NCT03863223 2022-11-23

A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer

590 enrolled

Breast Neoplasms

NCT01547741 2022-04-14

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

1,871 enrolled

Breast Neoplasms

NCT02512315 2021-08-30

A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

192 enrolled

Nasopharyngeal Carcinoma

NCT03119857 2021-08-18

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

349 enrolled

Prostatic Neoplasms

NCT03961867 2021-06-01

Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma

440 enrolled

Stomach Neoplasms

NCT04780750 2021-03-03

Concurent Chemoradiotherapy in Head and Neck Cancers

60 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03294577 2021-01-15

Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia

221 enrolled

Chemotherapy-induced Neutropenia

NCT04665986 2020-12-14

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

50 enrolled

Breast Neoplasms

NCT04502641 2020-08-06

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

160 enrolled

Hypopharyngeal Neoplasms

NCT01917279 2020-07-23

CAMELLIA

280 enrolled

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Skin Diseases

NCT04351867 2020-07-16

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

196 enrolled

Stomach Neoplasms

NCT04414566 2020-06-04

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

562 enrolled

Nasopharyngeal Carcinoma

NCT04385563 2020-05-13

A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.

338 enrolled

HER2-positive Metastatic Breast Cancer

NCT02076477 2020-03-17

OITROLC

420 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03944980 2019-06-14

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung Cancer

146 enrolled

IIIB/IIIC/IV Lung Cancer

NCT03949634 2019-05-14

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

272 enrolled

Breast Neoplasms

NCT00532727 2019-02-20

TNT

400 enrolled

Breast Neoplasms

NCT02434614 2018-05-16

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

440 enrolled

Nasopharyngeal Carcinoma

NCT02769104 2018-01-09

ACCN

120 enrolled

Breast Neoplasms

NCT03359694 2017-12-02

Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer

300 enrolled

Breast Neoplasms, Genetic Predisposition to Disease

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

1,206 enrolled 19 charts

Breast Neoplasms

NCT03061058 2017-09-15

Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC

240 enrolled

Stomach Neoplasms

NCT03269162 2017-09-14

Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection

144 enrolled

NSCLC

NCT02044354 2017-08-08

CABA-DOC

195 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT01222052 2017-06-26

NNBC3-Europe

4,150 enrolled

Breast Neoplasms

NCT01642771 2017-04-19

Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer

636 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03006614 2017-01-16

PERS

320 enrolled

Breast Neoplasms

NCT03015727 2017-01-10

IRCNPC

440 enrolled

Nasopharyngeal Carcinoma

NCT01630733 2016-07-01

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

700 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02786641 2016-06-01

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

235 enrolled

Nasopharyngeal Carcinoma

NCT02703961 2016-03-17

Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer

598 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02643407 2015-12-31

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

488 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT02633176 2015-12-17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

120 enrolled

Nasopharyngeal Carcinoma

NCT02621970 2015-12-04

Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma

534 enrolled

Nasopharyngeal Carcinoma

NCT01245959 2014-02-13

Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

476 enrolled

Nasopharyngeal Carcinoma

NCT00010140 2013-12-18

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Breast Neoplasms

NCT00022022 2013-12-18

Docetaxel in Treating Patients With Non-Small Cell Lung Cancer

200 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02001168 2013-12-04

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

392 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

350 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00376792 2013-08-26

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

396 enrolled

Prostatic Neoplasms

NCT00796458 2013-08-12

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

200 enrolled

Pain, Prostatic Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

2,500 enrolled

Breast Neoplasms

NCT01283217 2013-06-04

Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer

166 enrolled